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Heteroplasmy, the existence of multiple mtDNA types within an individual, has been previously detected by using mostly indirect
methods and focusing largely on just the hypervariable segments of the control region. Next-generation sequencing technologies should
enable studies of heteroplasmy across the entire mtDNA genome at much higher resolution, becausemany independent reads are gener-
ated for each position. However, the higher error rate associated with these technologies must be taken into consideration to avoid false
detection of heteroplasmy. We used simulations and phiX174 sequence data to design criteria for accurate detection of heteroplasmy
with the Illumina Genome Analyzer platform, and we used artificial mixtures and replicate data to test and refine the criteria. We
then applied these criteria to mtDNA sequence reads for 131 individuals from five Eurasian populations that had been generated via
a parallel tagged approach. We identified 37 heteroplasmies at 10% frequency or higher at 34 sites in 32 individuals. The mutational
spectrum does not differ between heteroplasmic mutations and polymorphisms in the same individuals, but the relative mutation
rate at heteroplasmicmutations is significantly higher than that estimated for all mutable sites in the humanmtDNA genome.Moreover,
there is also a significant excess of nonsynonymous mutations observed among heteroplasmies, compared to polymorphism data from
the same individuals. Both mutation-drift and negative selection influence the fate of heteroplasmies to determine the polymorphism
spectrum in humans. With appropriate criteria for avoiding false positives due to sequencing errors, next-generation technologies can
provide novel insights into genome-wide aspects of mtDNA heteroplasmy.Introduction
The mtDNA genome remains one of the most widely
studied DNA segments in humans. It is particularly useful
for studying population and evolutionary genetics because
of its abundance in human cells, its uniparental, nonre-
combining mode of inheritance, and its high mutation
rate compared to that of the nuclear genome.1 Although
each individual is typically characterized by a single
mtDNA type, in fact each individual is a population of
mtDNA genomes, and the presence of multiple mtDNA
types within an individual is termed heteroplasmy.
Although little noted at the time, the first report of het-
eroplasmy in humans was in 1983, involving a study of
a noncoding region of human mtDNA from 11 human
placentas.2 Heteroplasmy has been investigated most
often in correlation with mitochondrial disease, aging,
and cancer.3–6 To date, more than 400 mtDNA mutations
have been associated with human disease, and most were
observed in heteroplasmic states, with pathogenic muta-
tions coexisting with normal mitochondrial genomes.7
This suggests that the heteroplasmic level is of particular
interest, as the disease phenotype becomes evident only
when the percentage ofmutantmolecules exceeds a critical
threshold value. Although this value differs for different
mutations and in different tissues, it is usually in the range
of 70%~90%.8,9
Originally, heteroplasmy was believed to be quite rare in
healthy individuals,10,11 but subsequent studies found
many non-disease-related heteroplasmies.12–15 Moreover,1Department of Evolutionary Genetics, Max Planck Institute for Evolutionary
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The Americheteroplasmy has started to play an important role in
some forensic investigations.16,17 Thus, heteroplasmy can
also be a useful genetic marker. Regarding heteroplasmy
as the intermediate stage between the generation of muta-
tions and the fixation of mutations in the individual or
cell, it represents polymorphisms within the populations
of mitochondrial genomes in one cell or tissue. Thus, it
can be a potential resource for studying the mutational
pattern, possible role of natural selection, and even
the existence of recombination in mtDNA.18 For example,
de novo mtDNA mutations in cancer tissues preferen-
tially locate at the same positions as ancient variants in
the human phylogeny, indicating similar selective con-
straints.19 Understanding the basis, extent, and forces
influencing the occurrence and subsequent fate of hetero-
plasmic mtDNA mutations is one of the principal chal-
lenges facing scientists and clinicians in the field of mito-
chondrial genetics.
A variety of techniques have been employed for hetero-
plasmy detection, including Sanger capillary sequencing,13
high-performance liquid chromatography (HPLC),20
pyrosequencing,21,22 SnaPshot,23 high-resolution melt
(HRM) profiling,24 a temporal temperature gradient gel
electrophoresis (TTGE) strategy,25 the Invader assay,26 an
amplification refractory mutation system,27 and surveyor
nuclease.28 However, all of these methods have disadvan-
tages, including the following: for some methods, the
candidate heteroplasmic position needs to be defined first;
themethodmay not allow determination of the actual het-
eroplasmic position; the level of heteroplasmy cannot beAnthropology, D04103 Leipzig, Germany
.S.)
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quantified accurately; and/or the method is too labor
intensive to be applicable to large numbers of samples.
Moreover, the efficiency of detection can vary substan-
tially from laboratory to laboratory, even when the same
method is applied, as a result of different instruments,
chemistries, or standards for calling heteroplasmy.29,30 In
addition, most of the previous studies have restricted their
examination to the control region or the hypervariable
segments thereof; very few studies have analyzed hetero-
plasmies in the coding region,31 even though these are
likely to be of more importance for disease association.
Therefore, more accurate and efficient methods are needed
for the examination of heteroplasmy across the entire
mtDNA genome.
Next-generation sequencing technologies can, in prin-
ciple, provide the needed data, because millions of DNA
reads can be produced in a single run at low cost.32 This
technology has been widely used in the detection of SNPs
on a genome-wide scale,33–37 and in one such study,34
pooled DNA from 66 individuals was used to successfully
detect SNPs. More interestingly, this study also found
that the allele frequency inferred from the reads had
a significant correlation with that inferred from genotyp-
ing. Such DNA pools resemble the mtDNA heteroplasmy
scenario and therefore suggest that this approach should
be useful for heteroplasmy detection.
However, the relatively high sequence error associated
with next-generation sequencing technologies can pro-
duce false positives (i.e., sequencing errors may be falsely
considered to be heteroplasmies). Moreover, problems
could arise if PCR was involved during preparation of the
sequencing library, because PCR may alter the proportion
of different alleles and amplification error may also result
in false positives. In this study, we used simulations,
phiX174 control sequence data, artificial mixtures, and
replicates to design and evaluate criteria for accurate detec-
tion of heteroplasmic positions with the Illumina GA plat-
form. We then applied these criteria to a data set of
complete mtDNA genome sequence reads for 131 individ-
uals from five Eurasian populations that had been gener-
ated via a parallel tagged approach and sequenced with
the Illumina GA platform. The results of this large-scale
investigation provide insights into genome-wide patterns
of mtDNA heteroplasmy.Material and Methods
Data
ThemtDNA sequence reads used here were generated in a previous
study (unpublished data). In brief, the entire mtDNA genome was
amplified from 147 individuals from five populations (Georgia,
Armenia, Azerbaijan, Iran, and Turkey) in two overlapping prod-
ucts of about 9.7 and 7.3 Kb and sequenced on the Illumina
GAII platform (GAII; San Diego, CA, USA) via a multiplex
sequencing protocol for sequencing libraries;38,39 details are
described elsewhere (unpublished data). Out of 147 samples, the
reads from 131 met the criteria for accurate detection of hetero-238 The American Journal of Human Genetics 87, 237–249, August 1plasmy, developed below. Of these, 97 were sequenced once with
single-end 36 bp reads to an average coverage of 653, 17 were
sequenced twice with single-end 36 bp reads (because of insuffi-
cient coverage from the first lane) to an average of 783, and 17
were sequenced once with single-end 76 bp reads to an average
coverage of 2113. In addition, four samples originally sequenced
once with 36 bp reads were resequenced (with the use of new
PCR products amplified from the original DNA templates) with
single-end 76 bp reads for assessment of reproducibility.Assembly Strategy
The reads were assembled with the software MIA,40 the revised
Cambridge reference sequence (rCRS) used as the reference.41
MIA is optimized for circular genome assembling and performs
gapped assembling iteratively: after a consensus is called, the reads
are realigned to the consensus and a new consensus is called; this
process iterates until it converges on a single consensus sequence.
For the 36 bp reads, maximally, three mismatches or two mis-
matches plus one gap were allowed to successfully map the read,
whereas for the 76bp reads, five mismatches or four mismatches
plus one gap were allowed. In addition, any read with more
than two bases having a Phred-like quality score (QS) lower than
15 was removed (for 76 bp length reads, the threshold was five
bases with QS < 10), and duplicate reads (reads mapping to the
same position with same orientation on the reference) were
removed, keeping the one with the highest QS.Artificially Mixed Samples
The template DNAs from two individuals differing at 25 positions
in their complete mtDNA genome sequences were mixed in dif-
ferent proportions (1:1, 1:3, and 1:9). DNA concentrations were
measured by a NanoDrop ND-1000 spectrometer (NanoDrop
Technologies, Wilmington, DE, USA), diluted and mixed in the
desired proportions, and then used for long-rang PCR amplifica-
tion and Illumina GAII sequencing with 76 bp reads. These artifi-
cially mixed samples were used for examination of the correlation
between the heteroplasmy level (mixture proportion) and minor
allele frequency estimated from the reads.Simulation Framework
To evaluate the impact of sequencing error on the detection of
heteroplasmy, we performed simulations for varying levels of
sequencing error, heteroplasmy level, and sequencing depth. For
each simulation, one biallelic heteroplasmic position was assigned
to the genome randomly, with the heteroplasmy level (minor
allele frequency) set to be 5%, 10%, 20%, 30%, or 40%. Reads
with a specific length (36bp, 76bp) were generated randomly
from the rCRS to reach an average coverage of 363 or 763. The
sequencing error in the simulation was evenly distributed along
the reads and along the mitochondrial genome, with the error
rate set to be 1%, 0.5%, 0.3%, or 0.1%. Because Illumina GA
uses the same laser to excite two pairs of nucleotides (A/C and
G/T), the pairs produce similar emission spectra and are thus
poorly distinguished by optical filters, which results in a higher
proportion of errors involving A/C and G/T.39,42 On the other
hand, heteroplasmy is highly biased toward transitions (A/G,
C/T), as with mtDNA substitutions.13,14 We therefore specified
that all sequencing errors would be A/C or G/T changes, whereas
all heteroplasmy would involve A/G or C/T changes, so that we
could readily distinguish sequencing errors from heteroplasmy3, 2010
Figure 1. False-Negative Error Rate and
False-Positive Error Rate in Detecting Het-
eroplasmy Inferred from Simulation
False-negative error rate and false-positive
error rate calculated under different error
rates (1%, 0.5%, 0.3%, 0.1%), coverage
(363, 763), heteroplasmy levels (minor
allele frequencies of 10%, 20%, 30%,
40%), and frequency thresholds used to
define heteroplasmy (40%, 30%, 20%,
10%). For each setting, the simulation
was repeated 100 times. FP denotes the
false-positive error rate, FN denotes the
false-negative error rate.in our simulations. For each setting, the simulation was repeated
100 times.
PhiX174 Data for Permutation Test
In each Illumina GA sequencing run, the phiX174 bacteriophage
genome is sequenced on a separate lane to very high coverage
(about 60,0003) and then used as a control for sequencing-error
correction for that run. Theoretically, there should be no hetero-
plasmy in the phiX174 genome, given that it is from a single
strain, although in fact Illumina technical support reports five
SNPs in phiX174 genome sequences. Therefore, we applied our
criteria for detecting heteroplasmy to the phiX174 data, to esti-
mate the false-positive error rate associated with various criteria.
To simulate different sequencing depths, we retrieved subsets of
the reads from the phiX174 control, and for each depth (15-, 30-,
60-, 90-, 120-, 150-, 180-, 210-, 600-, and 1200-fold average
coverage), we repeated the simulations 100 times.
MtDNA Polymorphism Data
Polymorphic positions were retrieved from Mitomap,7 mtDB,43
4775 whole mitochondrial genomes from GenBank,44 and 700
whole mitochondrial genomes from our laboratory (unpublished
data). The relativemutation rate (RMR) for each polymorphic posi-
tion was retrieved from Soares et al.45 Disease-associated positions
were retrieved also from Mitomap7 (April 27, 2010 version); when
defining a heteroplasmy as disease-associated, both the nucleotide
position and the specific mutation were considered.
Haplogroup-defining positions were retrieved from Phylotree,46
and an in-house script was used to collect all the haplogroup-
defining positions and the corresponding mutation type, which
were then used to identify heteroplasmies occurring at such hap-
logroup-defining positions.
Validation of Heteroplasmies
To independently verify the heteroplasmic positions inferred
from high-throughput sequencing, we performed single-baseThe American Journal of Human Gextension assays for nine heteroplasmic
sites. Primers were designed to amplify
shorter products around these sites for
both control and heteroplasmic individ-
uals with the use of original DNA as
template (Table S1, available online). All
single-base extension assays were carried
out with the ABI Prism SnaPshot Kit
(Applied Biosystems), with amplicons
detected via capillary electrophoresis onan ABI Prism 3100 Genetic Analyzer according to the manufac-
turer’s instructions.
Results
Sequencing Overview
A total of 45 million reads were generated for the 131
samples and four replicates, and 94% of the reads could
be mapped to the rCRS. For the 36 bp reads, the average
coverage was 675 7 (mean5 standard deviation); mean-
while, 96.8% of the positions had coverage greater than
363 and at least ten reads for each strand. For the 76 bp
reads, the average coverage was 2115 21, and 98.6% posi-
tions had coverage greater than 363 and at least ten reads
for each strand.
Simulations
We used simulations to explore the effects of different
sequencing error rates, coverage, and threshold of the
minor allele frequency to define heteroplasmy, on the
false-positive error (i.e., calling a sequencing error a hetero-
plasmy) and false-negative error (i.e., failing to call a true
heteroplasmy) rates. Results are shown in Figure 1; 363
coverage is close to the lowest coverage that we have in
our samples, whereas 763 coverage is close to the average
coverage in our samples. The results illustrate the tradeoff
that occurs between the false-positive and false-negative
rates. When the heteroplasmy threshold is set relatively
high (more than 10%), there are no false positives, even
with a high sequencing error rate, but the false-negative
rate is quite high, indicating that many true heteroplas-
mies will be missed. When the threshold is set relatively
low (10% or less), the false-negative rate becomes veryenetics 87, 237–249, August 13, 2010 239
Table 1. Number of Heterozygous Positions Detected in the
PhiX174 Genome under Different Criteria
No Quality Filter QS R 20 QS R 23
Validated by
one strand
582.9 5 40.9a 192.8 5 14.0 126.35 24.6
Validated by
two strands
17.9 5 4.7 3.05 1.4 1.95 1.0
a Standard deviation based on 100 resamplings of the data.
Table 2. Number of Heteroplasmies Detected with PhiX174
Permutation Data
Frequency Threshold
One Direction Two Directions
Detection Rate 0.05 0.1 0.2 0.3 0.4 0.05 0.1 0.2 0.3 0.4
> 50% 3 1 1 1 1 1 1 1 1 1
25%–50% 2 0 0 0 0 0 0 0 0 0
10%–24% 2 2 0 0 0 0 0 0 0 0
5%–9% 2 2 0 0 0 1 0 0 0 0
< 5% 8 0 0 0 0 0 0 0 0 0low, but now the false-positive rate becomes unacceptably
high. Acceptable false-positive and false-negative rates can
apparently be achieved only if the sequencing error rate
can be reduced to 0.1% (Figure 1) or if the average coverage
is increased.PhiX174 Analysis and Development of Criteria
The phiX174 genome is routinely sequenced to very high
coverage in a separate lane in each Illumina GAII run, in
order to provide baseline error rates for the base-calling soft-
ware. Because in theory the phiX174 data should come
from a single pure strain, there should not be any polymor-
phism, although five SNPs have been reported (Illumina
technical support). Thus, any ‘‘heteroplasmic’’ position
after assembly is presumably caused by sequencing error.
We therefore investigated other ways to reduce false posi-
tives by applying various criteria to the phiX174 reads.
Reads were randomly retrieved from the control lane to
simulate a sequencing depth of 64-fold, and this procedure
was repeated 100 times for each analysis. The number of
heterozygous positions (defined as positions with at least
one read with an alternative base) after assembly is shown
in Table 1. Sequencing error is indeed an important issue,
because in the absence of any QS filtering, 11% (583 out
of 5386) of the positions were affected, and some of them
can even reach a minor allele frequency between 20%
~30%. QS filtering can improve the situation, but even
a fairly stringent QS (QSR 23) leaves many heterozygous
positions (Table 1). However, double-strand validation
(i.e., requiring at least one read from each strand) consider-
ably reduces the impact of sequencingerror;withnoquality
filter, double-strand validation reduces the average number
of heterozygous positions from 583 to 18 (Table 2). And
with a combination of a stringent quality filter and
double-strand validation, only two heterozygous positions
are detected on average. Note that this better performance
of double-strand validation was not caused by any bias in
the number of reads in one direction, because all positions
have a coverage greater than40andat least ten reads in each
direction. Instead, sequence errors tend to be context
specific, and hence the majority of sequence errors are
found on only one strand.
To investigate the performance of double-strand valida-
tion with various frequency thresholds for calling hetero-
zygous positions, we carried out additional simulations
using an average coverage of 66, to mimic our real data.
Table 2 compares the results of single- versus double-strand240 The American Journal of Human Genetics 87, 237–249, August 1validation for various thresholds (for other sequencing
depths, see Table S2), requiring QS R 20 at the position
in question (and QS R 15 for the 5 bp flanking sequence
on each side). As expected, a lower frequency threshold
resulted in a higher false-positive rate, but only one false
positive was consistently detected with double-strand vali-
dation and a frequency threshold of 10% or more. This
position (1301) is not included in the five SNPs previously
reported, but it has been found to be polymorphic by
another laboratory (T. Skelly, personal communication),
so it is likely to be a novel SNP in the phiX174 genome.
On the basis of both the simulations and the phiX174
analyses, we decided on the following criteria for calling
a heteroplasmic position: QSR 20 at the position in ques-
tion, QS R 15 at the 5 bp flanking either side, a minor
allele frequency of at least 10%, and the minor allele
observed in at least one read in each direction. These
criteria should result in no false positives, and we should
have 100% power to detect heteroplasmies present at
a frequency of 20% or more and 50% power to detect het-
eroplasmies at a frequency of 10%.
Artificially Mixed Samples and Improvement
of the Criteria
To test the sensitivity and specificity of these criteria, we
applied them to three artificially mixed samples consisting
of DNA derived from two individuals in different ratios
(1:9, 1:3, 1:1) whose mtDNA genome sequences differ at
25 positions. All 25 positions were observed to be hetero-
plasmic, with inferred frequencies closely corresponding
to those expected (Figure 2), except for six positions for
the 1:9 mixture, which fell close to, but below, the 10%
threshold. The Pearson correlation coefficient between the
heteroplasmic level estimated from sequencing and the
actual proportion is 0.944 (p < 0.001), in good agreement
with a previous study of artificially mixed samples ana-
lyzed by high-throughput sequencing.47 Four potential
false positives were observed: position 7030AC (the first
letter denotes the majority nucleotide and the second
letter the minority nucleotide), with a minor allele fre-
quency of 12% in the sample with a 1:1 ratio; position
13604GA, with minor allele frequencies of 10% and 12%
in the 1:3 and 1:9 mixtures, respectively; and the A3, 2010
Figure 2. Heteroplasmy Level Estimated from Sequencing
Reads for the Expected Heteroplasmic Positions in the Artificially
Mixed Samples
Horizontal lines indicate the expected heteroplasmy levels. The
rightmost column gives the mean and standard error of the
mean value of all heteroplasmic positions under each mixture
ratio.homopolymer region beginning at 12418, where 11% of
the reads have 7A and 89% have 8A in the 1:9 mixture.
However, as shown below, position 13604GA is actually
inferred to be heteroplasmic, with a minor allele frequency
of 11%, in the sample (Ir43) that was used as the major
component in the mixed samples. Moreover, the A homo-
polymer region beginning at 12418 was heteroplasmic in
both of the samples, with a minor allele (7A) frequency
of 12% and 10%, respectively. Therefore, only position
7030 qualifies as a true false positive. A more stringent
requirement of QS R 23 at the heteroplasmic position
(rather than QS R 20) would eliminate this false positive,
but it would also remove an unacceptably high number
of other reads for the true heteroplasmies. However,
requiring two distinct reads from each strand would also
eliminate this false positive while retaining all of the other
inferred heteroplasmies. Therefore, we adjusted the criteria
for heteroplasmy to require that the minor allele was
observed in at least two independent reads from each
strand.Frequency Variation between Replicates
Four samples were sequenced twice independently, allow-
ing us to assess how inferred minor allele frequencies
varied between replicates. The average frequency variation
between replicate pairs was 0.0057 5 0.011, and there
were 42 positions having a minor allele frequency differ-
ence greater than 0.1 (Figure 3). More stringent QS filtering
(QSR 23 for the position in question and QSR 20 for the
5 bp flanking sequence on each side) reduced but did not
eliminate the discrepancies; 19 positions still had a minor
allele frequency difference greater than 0.1. Moreover, low
coverage does not appear to play a significant role, because
only five positions have a coverage lower than 10 in one of
the replicates.The AmericHowever, for 21 of the 42 positions with a minor allele
frequency difference bigger than 0.1, the nucleotides
involved were A and C (Table S3). Moreover, for many of
these positions, the minor allele is observed on only one
strand, indicating that the discrepancy between replicates
is due to an increase in theminor allele on one strand only,
consistent with sequencing errors. This same pattern was
observed for another four positions in which A and T
were involved (Table S3). The one exception to this pattern
is position 385 for Az41, for which A andG are observed on
both strands in both replicates. The frequency of theminor
(G) allele was 20% versus 8.7% in the replicates; however,
the difference was not significant (p ¼ 0.059, Fisher’s exact
test). It is likely that this is a real heteroplasmic position
and that the frequency difference between replicates is
due to stochastic effects. All of the remaining 16 positions
were located in the homopolymer region, for which
inaccurate alignment can explain the large minor allele
frequency difference.
Genome-wide Characterization of Heteroplasmy
Application of the criteria developed above to the full data
set of 131 individuals resulted in the detection of 37 point
heteroplasmies among 32 individuals (Table 3), or 24% of
the individuals studied. The average coverage for the heter-
oplasmic positions is 79 (range: 28–170), and for only
four positions (3014GT, 3492AC [twice], 10208CT) was
the minor allele observed in fewer than six reads. Five
individuals possessed two heteroplasmies each; overall,
the number of heteroplasmies per individual did not dif-
fer significantly from the expectation when 37 heteroplas-
mies are randomly assigned to 131 individuals (p > 0.05).
There were also no significant differences in how hetero-
plasmies were distributed among populations or among
haplogroups. However, three heteroplasmies (146CT,
3492AC, 16223TC) occurred at the same position in two
different individuals who belonged to different popula-
tions and had different mtDNA haplogroups; thus,
these are likely to represent independent heteroplasmies.
This is significantly more than expected by chance if
heteroplasmies occur randomly across themtDNA genome
(p < 0.001).
We also detected three indel heteroplasmies (outside
homopolymer regions) among three individuals (Table 4).
One of these was located in a tRNA gene, whereas the other
two were in the control region. In addition, we observed
another 112 indels in the following homopolymer and
STR regions (with the variation observed indicated in
parentheses): 66~71 (5C-6C), 303~309 (6C-9C), 514~523
(5CA-6CA), 12418~12425 (7A-8A), and 16184~16193
(9C-12C). Even if we only use the reads that span these
homopolymer and STR regions, we still observed these
length variations in at least two distinct reads per strand.
However, slippage of the DNA polymerase during replica-
tion can also result in length variation, which is frequently
observed in the homopolymer and STR region.48,49
Therefore, the indel heteroplasmic regions would needan Journal of Human Genetics 87, 237–249, August 13, 2010 241
Figure 3. Distribution of Frequency
Differences between Replicates
Only positions with a frequency difference
greater than 0.01 are shown.additional validation, ideally by a method that does not
require PCR amplification, and for this reason we do not
include these regions in our analysis of heteroplasmy.
Validation of Heteroplasmies
We selected nine heteroplasmic sites for independent
validation via single-base extension assays. For each site,
the predicted heteroplasmy state was observed in the cor-
responding individual (Figure S1), whereas control individ-
uals lacking the heteroplasmy displayed only single peaks
in the assays (data not shown). These results indicate
that the heteroplasmies inferred by analysis of high-
throughput sequencing reads are indeed true heteroplas-
mies, because they are validated by another method.
Patterns of Heteroplasmy Variation
Thirteen of the 34 heteroplasmic positions are located in
the control region, which is more than expected by chance
if heteroplasmic positions are distributed randomly across
the mtDNA genome (p < 0.001, chi-square test). The ratio
of transitions to transversions at heteroplasmies is 8.25,
which is not significantly different (p ¼ 0.616, Fisher’s
exact test) from the ratio of 8.09 for polymorphic positions
in the same individuals. Moreover, the mutational spec-
trum for heteroplasmies does not differ significantly from
that for polymorphisms in the same populations, or from
the mutational spectrum for polymorphisms reported in
the Mitomap database (Figure 4).
For investigation of the correlation between the inci-
dence of heteroplasmy and mutation rates, the RMR for
each heteroplasmic position was obtained from a previous
study.45 We classified the heteroplasmic positions into
three categories: entire genome, control region, and cod-
ing region; the comparisons of RMR between heteroplas-
mic positions with all positions and all mutable positions
in each category are shown in Table 5. Heteroplasmic posi-242 The American Journal of Human Genetics 87, 237–249, August 13, 2010tions have higher mutation rates in
all categories, significantly so except
when compared to all mutable posi-
tions in the coding region. Overall,
heteroplasmies are occurring prefer-
entially at positions with high muta-
tion rates. This is particularly evident
in the control region, in which six of
the ten positions with the highest
mutation rates (Soares et al.45) were
found to exhibit heteroplasmy in our
study.
We detected 21 heteroplasmies at
20 positions in the protein-coding
genes (3492AC is shared by two indi-viduals). Ten of these are nonsynonymous mutations, ten
are synonymous mutations, and one is located in the
overlap region involving the ATP6 (MIM 516060) and
ATP8 (MIM 516070). There is an excess of nonsynony-
mous mutations at the heteroplasmic positions when
compared to polymorphism data from the same individ-
uals (164 nonsynonymous and 385 synonymous muta-
tions; p¼ 0.051, Fisher’s exact test) or to a previous study50
(413 nonsynonymous and 1037 synonymous mutations;
p ¼ 0.045, Fisher’s exact test).
Five of the ten nonsynonymous heteroplasmies are
located at positions with an assigned RMR,45 and one of
them is located at the position with the highest RMR
among 824 nonsynonymous mutations (5460AG, RMR ¼
36). Two other nonsynonymous heteroplasmies also have
high RMR (15314GA, RMR ¼ 12; 11253CT, RMR ¼ 5),
whereas the other two (7754AG, 8743GA) both have
RMR ¼ 1. The heteroplasmic nonsynonymous sites tend
to have higher mutation rates than previously reported
nonsynonymous mutations in polymorphism data45
(p ¼ 0.068, Mann-Whitney test). The other nonsynony-
mous heteroplasmies—3492AC (which occurred twice),
3532AG, 14561AG, and 13604AG—have never been
observed as polymorphisms (based on sequences retrieved
from Mitomap,7 mtDB,43 and GenBank, as well as 700
unpublished mtDNA genome sequences from our labora-
tory). The overall ratio of nonsynonymous heteroplasmies
at sites without previously reported mutations, 5/10, is
significantly higher than that observed in polymorphism
data from the same individuals, 23/164 (p ¼ 0.01, Fisher’s
exact test). There is thus a dichotomous tendency for non-
synonymous heteroplasmies to occur either at rapidly
evolving sites or at sites that have not been observed as
polymorphisms. Eight of the ten synonymous mutations
have an assigned RMR;45 the average RMR for these eight
positions is 3.0 5 2.6, which is higher than the overall
Table 3. Point Heteroplasmies Detected in 131 Individuals
Position Individual Coverage Major Allele Frequency Minor Allele Frequency Gene Annotationa
64 Ir28 82 T 0.87 C 0.13 CR
146 Ir17 62 T 0.90 C 0.10 CR
146 G65 186 T 0.80 C 0.20 CR
150b Arm17 69 C 0.88 T 0.12 CR
152 Ir11 71 T 0.89 C 0.11 CR
195b G67 67 T 0.90 C 0.10 CR
203 Az5 67 A 0.66 G 0.34 CR
204 Arm17 75 T 0.89 C 0.11 CR
1552 Ir54 69 G 0.87 A 0.13 12S
3014 Az10 44 G 0.86 T 0.14 16S
3492 Arm25 60 A 0.65 C 0.35 NS(ND1; Lys>Asn)
3492 G20 63 A 0.78 C 0.22 NS(ND1; Lys>Asn)
3532 Az14 73 A 0.82 G 0.18 NS(ND1; Thr>Ala)
4991 Az4 173 G 0.65 A 0.35 S(ND2)
5460b Az7 136 A 0.68 G 0.32 NS(ND2; Thr>Ala)
7754 T186 73 A 0.89 G 0.11 NS(COX2; Asn>Asp)
8152 Az46 80 G 0.88 A 0.13 S(COX2)
8551 Ir30 67 C 0.54 T 0.46 S/NS(ATP6/ATP8)
8743 Ir29 75 G 0.68 A 0.32 NS(ATP6; Val>Met)
10208 Ir10 57 C 0.89 T 0.11 S(ND3)
10427 Az39 68 G 0.85 A 0.15 tRNA-ARG
11253b G1 68 C 0.76 T 0.24 NS(ND4; Thr>Ile)
11692 G38 72 A 0.76 C 0.24 S(ND4)
11809 G82 72 T 0.78 C 0.22 S(ND4)
12654 Arm37 69 A 0.86 G 0.14 S(ND5)
13368 Arm19 196 G 0.54 A 0.45 S(ND5)
13604 Ir43 68 G 0.90 A 0.10 NS(ND5; Ser>Asn)
14527 G25 66 A 0.89 G 0.11 S(ND6)
14561 T9 63 A 0.78 G 0.22 NS(ND6; Asp>Gly)
14770 Az14 77 T 0.55 C 0.45 S(CYTB)
15046 T186 62 G 0.74 A 0.26 S(CYTB)
15314 Arm20 206 G 0.84 A 0.14 NS(CYTB; Ala>Thr)
16093 Az49 147 C 0.91 T 0.08 CR
16217 T30 65 C 0.91 T 0.09 CR
16223 G73 178 T 0.89 C 0.11 CR
16223 Arm20 190 T 0.89 C 0.11 CR
16362 G67 76 T 0.87 C 0.13 CR
a The abbreviations used for gene annotation: CR: control region; 12S: 12S rRNA; 16S: 16S rRNA; S: synonymous; NS: non-synonymous. Gene name is displayed if
it happens in the protein-coding genes, and amino acid change is displayed for non-synonymous mutation.
b Disease-associated positions reported by Mitomap.7
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Table 4. Indel Heteroplasmies Detected in 131 Individuals
Position Individual Coverage Allele 1 Frequency Allele 2 Frequency Gene Annotation
57 Ir28 82 C 0.84 - 0.16 CR
15940 Arm2 208 - 0.85 T 0.15 tRNA-THR
248 Ir10 68 A 0.84 - 0.16 CRRMR of 2.0 for synonymous mutations, but not sig-
nificantly so (p ¼ 0.187, Mann-Whitney test). The other
two synonymous mutations have not been previously
observed as polymorphisms and hence do not have an
assigned RMR.
Finally, two heteroplasmic positions (3014GT, 1552AG)
are located in the stems of rRNA genes,51,52 with the major
alleles identical to the rCRS, and were not observed to be
polymorphic in the database. One heteroplasmic position
(10427AG) is located in the connection of two stems of
the tRNA-ARG (MIM 590005),53 and this position has an
RMR of 2.0.Disease-Associated Heteroplasmies
Four of the 34 (11.8%) heteroplasmic positions are re-
ported as disease-associated in Mitomap7 (Table 3), which
is more than expected by chance (2.5% of all mtDNA posi-
tions are reported to be disease-associated in Mitomap;7
p ¼ 0.010, permutation test). However, all of these posi-
tions have also been reported previously as polymor-
phisms; moreover, there is also an excess number of poly-
morphisms at disease-associated sites in the mtDNA
genome sequences from the same individuals (6.1%; p <
0.001, permutation test).
It seems likely that disease-associated mutations with
mild effects will be observed as polymorphisms in ‘‘nor-
mal’’ individuals more frequently than disease-associated
mutations with strong effects. Overall, 22.4% of the
disease-associated mutations in Mitomap are also present
in normal populations and 77.4% are absent in normalFigure 4. Mutation Spectrum for the Heteroplasmy and Poly-
morphism Data
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mic positions are observed as polymorphisms in normal
populations, which is significantly more than expected
(p ¼ 0.003, permutation test). Moreover, the average RMR
for these four disease-associated heteroplasmic positions is
51, which is significantly higher than the average RMR of
2.72 for all mutable positions (p < 0.001, Mann-Whitney
test) and significantly higher than the average RMR of
8.8 for all disease-associated positions that also present
as polymorphisms in normal populations (p ¼ 0.007,
Mann-Whitney test).Discussion
We first discuss issues related to the criteria for detecting
heteroplasmy, and we then discuss the implications of
our results.
Reducing the Impact of Sequencing Errors
Although the high-throughput sequencing technologies
have a higher per-base sequencing error rate compared
with the traditional capillary sequencers, the new technol-
ogies still give highly accurate sequences because of the
higher sequencing depth.39,42,54 However, this holds only
for assembling a consensus sequence or calling SNPs, in
which using a ‘‘majority rule’’ eliminates the impact of
sequencing error and produces the desired result. Trying
to detect heteroplasmy presents different issues, because
the minor allele at the heteroplasmic position may be
indistinguishable from sequencing error. QS filtering can
help eliminate sequencing errors but is insufficient to
completely solve the problem (Table 1).
The most obvious way to distinguish between
sequencing errors and heteroplasmy is to invoke a
threshold. Sequencing errors happen at a specific rate
(102~103, based on our unpublished data and other
studies39), so frequency of an error observed at low coverage
should decrease to this level with higher coverage, whereasTable 5. Relative Mutation Rate at Heteroplasmic Positions
Heteroplasmic
Positions All Positions
All Mutable
Positions
Whole genome 24.95 0.645a 2.72a
Control region 64.08 3.74a 7.01a
Coding region 4.2 0.469a 2.05
a Significantly different from that of heteroplasmic positions at the p < 0.001
level in the Mann-Whitney test.
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the level of heteroplasmy should not change with the
coverage. However, sequencing errors are reported to be
position dependent and context dependent.36,39,42 In
fact, we have observed several sequencing error ‘‘hot spots’’
(including 257AC, 3492AC, 3511AC, 4774TA, 5290AT,
9801GT, 10306AC, 10792AC, 11090AC), defined here as
meeting the following criteria: (1)R 10%of the individuals
have the minor allele with frequency R 10% at this posi-
tion, but (2) the minor allele forR 90% of the individuals
cannot be validated by reads from both strands. As ex-
pected, most of the sequencing-error hotspots involve
misidentification of A to C; thus, some errors can reach
a high enough frequency to pass a simple frequency-
threshold criterion and contribute to false positives.
However, given that heteroplasmy is not strand depen-
dent and that it is highly unlikely that an error-prone
context would exist for the same position on both strands,
a useful filter is double-strand validation: heteroplasmies
are called only if both of alleles can be detected by reads
from both strands. Double-strand validation alone signifi-
cantly reduced the number of heterozygous positions
detected in the phiX174 sequence data (Table 1). However,
even double-strand validation is not sufficient to eliminate
all sequencing errors: one position (7030AC) in the artifi-
cially mixed samples passed this filter but is a false positive.
This can occur because sequencing error also occurs in the
other direction by the usual background error rate (e.g.,
with 40 reads in the non-error-prone direction and an error
rate of 0.3%, there is an 11% chance of observing at least
one error). We therefore implemented the requirement of
observing both alleles in at least two independent reads
from each direction to validate the heteroplasmy, and
the number of reads required on both strands should be
increased with a higher sequencing depth. Although this
requirement appears to be sufficient to eliminate virtually
all false positives due to sequence errors, it does increase
the probability of false negatives due to failure to observe
a trueminor allele in at least two reads from each direction,
especially when coverage is low.
Another aspect of Illumina GA sequencing errors is that
they tend to be position dependent: typically, the error rate
at the end of the read is approximately 2- to 6-fold higher
than at the beginning. One potential way to reduce the
false-positive errors that are caused by position-dependent
error might therefore be to require that heteroplasmies are
validated by the beginning or middle of reads. Indeed, this
requirement significantly reduced the number of heterozy-
gous positions in the phiX174 reads (see details in Table
S4). However, our data also suggest that the error at the
ends of the reads is equivalent to that in the middle of
the reads under the QS filtering that we applied (QS R
20 for the position in question and QS R 15 for the 5 bp
flanking sequence on each side), which may reflect the
fact that QS is correlated with the position in the read.
We therefore did not include the requirement of confirma-
tion by the beginning or middle part of the reads in order
to call a heteroplasmy.The AmericImpact of Assembly Strategy on Calling
of Heteroplasmies
In addition to sequencing errors, inaccurate assembly
of the reads can create artificial heteroplasmies, because
the minor allele could come from reads originating
from another part of the mtDNA genome. To evaluate
whether heteroplasmy is caused by improper alignment,
we removed all reads with multiple best hits on the final
consensus sequence (i.e., mapping quality equals 0 when
assembling the reads by using Burrows Wheeler alignment
as implemented in the software BWA55), and none of the
inferred heteroplasmies disappeared. Therefore, incorrect
assembly does not appear to be influencing our results.
Another question concerning the assembly is whether to
use all reads or only unique reads (i.e., those with different
start and/or endpoints) from high-throughput sequencing
data.56–58 The concern is that duplicate reads may repre-
sent copies from the same molecule rather than indepen-
dent reads. We examined this question in the artificially
mixed samples and found that using unique reads versus
all of the reads does not influence the detection and level
of heteroplasmy (results not shown). However, when we
resampled the reads from the 1:3 mixture to investigate
the influence of sequencing depth, using duplicate reads
resulted in higher false-positive and false-negative error
rates than using unique reads (Table S5). Apparently,
with low coverage even a small number of duplicate reads
can have a large impact on the inferred minor allele
frequency. Because a large fraction (~27%) of the positions
in our samples have a sequencing depth less than 1503,
we used only the unique reads to infer heteroplasmies.
Impact of PCR on Calling of Heteroplasmies
PCR is another factor influencing the detection of hetero-
plasmy; biased amplification can alter the minor allele fre-
quency, and sequence error introduced during PCR ampli-
fication may be falsely detected as heteroplasmies.59,60
However, several observations indicated that PCR has
had little or no effect on our analyses: nine inferred heter-
oplasmy were genotyped by single-base extension assays,
and all nine were validated; the inferred heteroplasmy
level in artificially mixed samples was close to the mixture
ratio; and sequencing of four samples in duplicate showed
no frequency difference greater than 10% that could be
validated by the double-strand criterion. It should be noted
that all PCR products used in the above studies were inde-
pendently amplified from the original DNA template.
Therefore, possible artifacts from the PCR process do
not appear to be influencing our inferences concerning
heteroplasmy.
Other Factors that Influence the Detection
of Heteroplasmy
Besides sequencing error, assembly error, and PCR artifacts,
there are other processes that could potentially influence
the identification of heteroplasmic positions by generating
false positives. These include jumping PCR,61 inadvertentan Journal of Human Genetics 87, 237–249, August 13, 2010 245
sequencing of nuclear mitochondrial pseudogenes
(numts),48,62 contamination during the library prepara-
tion, and the ‘‘stochastic effect’’ produced by random
sampling of sequencing reads. To what extent could these
be responsible for the heteroplasmies that we detected in
this study?
The first possibility is jumping PCR, which could result
in the incorrect allocation of a read to an individual,
because a parallel tagged approach was used in our study.61
However, after the indexing PCR of seven cycles, no addi-
tional PCR was performed on the pooled samples, so jump-
ing PCR should not be a problem.
Numts are another potential source of contamination
during mtDNA PCR amplification, because there are 46
paralogous nuclear DNA fragments that represent the
entire mitochondrial genome.62 However, instead of short-
range PCR or capture-based methods, which may be more
severely influenced by numts, we utilized long-range PCR.
No secondary amplification products were observed, and
moreover, 94% of the reads could be mapped to the
mtDNA genome, indicating that the reads are indeed orig-
inating from authentic mtDNA and not from numts.
Inadvertent sample mixtures or contamination could
also produce the appearance of heteroplasmy (indeed,
this was the basis for the artificially mixed samples). To
verify that such contamination does not explain inferred
heteroplasmies, we checked whether the content of the
heteroplasmies in one individual could be used to define
two different haplogroups in Phylotree.46 In fact, several
individuals in the original study (unpublished data) did
exhibit numerous putative heteroplasmic positions that
could be explained by sample mixtures involving two
different haplogroups; these individuals were excluded
from further analysis. In the 131 individuals used in this
study, sample mixtures involving any known haplogroups
cannot explain the inferred heteroplasmies.
A final concern is the ‘‘stochastic effect,’’ i.e., how much
variation can occur in sample replicates, and how this
would influence the inference of heteroplasmy. In the
four replicates, everything was repeated from the template
DNA via the samemethods; thus, any allele frequency vari-
ation for each position between these replicate pairs
should be caused by the stochastic effect. Although the
‘‘stochastic effect’’ could result in frequency variation
greater than 0.1, none could be validated by the double-
strand criteria, indicating that stochastic effects are
unlikely to produce false positives under our criteria for
detecting heteroplasmy.
Genome-wide Insights into Heteroplasmy
As discussed above, the heteroplasmies detected by our
criteria are unlikely to be caused by sequencing errors or
other artifacts. We now discuss the insights provided by
this large-scale examination of mtDNA genome-wide het-
eroplasmy. We identified 37 point heteroplasmies and
three indel heteroplasmies among 33 of 131 individuals
(25%), which is higher than the range of 3.8%–6%246 The American Journal of Human Genetics 87, 237–249, August 1reported in previous studies that used other methods.13,63
We attribute this higher rate to the increased sensitivity
that high-throughput sequencing offers for detecting
heteroplasmy and to the fact that we are analyzing hetero-
plasmy across the entire mtDNA genome, whereas pre-
vious studies focused on the control region.
The familiar transition bias in human mtDNA mua-
tions64 was observed, in that 89% of the point heteroplas-
mies are transitions. Thirteen point heteroplasmies (35%)
were found in the control region, which is more than
expected, and all of them are located in hypermutable
positions (RMR R 6). An association between hetero-
plasmy and hypermutable positions was found previ-
ously,65 and overall, these results suggest that mutation is
the major driving force behind heteroplasmy and that a
mutation-drift process can explain how heteroplasmies
arise, drift to high frequencies within an individual, and
eventually become ‘‘fixed’’ as polymorphisms among
individuals.
However, in the protein-coding region, mutations are
located in both hypermutable positions and hypomutable
positions. Altogether, eight heteroplasmies are located in
positions that have never been reported to mutate, which
is more than expected by chance (p ¼ 0.04). Moreover,
there is a significant excess of heteroplasmies involving
nonsynonymous changes in comparison to polymor-
phism data. It thus seems as if deleterious mutations arise
as heteroplasmies and can reach appreciable frequencies
(> 10%) within individuals but do not drift to fixation.
Instead, purifying selection must be operating on some
heteroplasmies to prevent their fixation within individ-
uals. Although purifying selection on mtDNA has been in-
ferred from other studies,66–68 no previous evidence of
such selection involving heteroplasmy has been found,69
which may reflect the limited number of heteroplasmies
previously studied in the coding region.
Significantly more heteroplasmies were detected in
disease-associated positions than expected by chance, but
all of them were also observed to be polymorphic in the
same population or in our polymorphism data set and,
moreover, are associated with high mutation rates. These
are not characteristics expected to be associated with dele-
terious mutations and hence may reflect limitations on the
accuracy of studies that attempt to elucidate disease-associ-
ated mtDNA mutations. Or, these may be associated with
mild effects on the phenotype. Still, we found that even
in comparison to the polymorphism profile, there is an
excess number of heteroplasmies in disease-associated
positions. It is thus possible that these disease-associated
heteroplasmies may drift to high enough frequencies
within an individual to result in the disease phenotype
and/or that they will be removed by purifying selection.
Detecting Heteroplasmy by High-Throughput
Sequencing Technology
We have developed a set of criteria to detect heteroplasmy
in complete human mtDNA genomes from the reads3, 2010
generated by Illumina GAII technology. Recently, another
study used the same sequencing technology to investigate
mtDNA heteroplasmy.14 This study sequenced only one
individual per lane, to an average coverage of ~16,000,
and hence used a correspondingly lower threshold for
the minor allele frequency of 1.6% to call heteroplasmic
positions. They detected 40 heteroplasmies above this
threshold in ten healthy individuals;14 of these, seven het-
eroplasmies in four individuals had a minor allele fre-
quency greater than the 10% threshold that we used.
This is significantly more than the 37 point heteroplasmies
that we detected among 131 individuals (p ¼ 0.02, resam-
pling test). Possible reasons for this difference include:
a higher false-negative error rate in our study, which is
due to lower sequencing depth; the different tissues used
(blood and saliva in our study, colonic mucosae in their
study14); and/or the relatively old age of individuals in
their study.14
Although sequencing to a much higher depth obviously
increases the power to detect heteroplasmies by lowering
the minor allele frequency threshold, stringent quality
control procedures are still necessary to determine a proper
frequency threshold. In fact, we note that in the previous
analysis of heteroplasmic variants among tissues from
a single individual (Table 2 of He et al.14), five of 14
heteroplasmies (36%) involve AC/GT changes, which is
the most common sequencing error on the Illumina
GA platform. This is significantly more than the 9%
frequency of AC/GT changes among heteroplasmies in
our study (p < 0.05), and it therefore suggests that some
of these are likely to reflect false positives due to
sequencing errors.
The strategy used to detect heteroplasmic variants
can therefore vary, depending on the goal of the study
(and available funding). Sequencing one sample per lane
(or even one sample on multiple lanes) will lower the
threshold for detecting heteroplasmic variants but will
increase the cost and therefore limit the number of sam-
ples that can be studied. Parallel tagged approaches, which
were used here, result in lower coverage and hence require
a higher minor allele frequency to call a heteroplasmy, but
they are a more cost-efficient approach for analyzing heter-
oplasmy in a large number of samples. Indeed, we predict
that the next few years will see a huge increase in complete
mtDNA genome sequences generated to an average
coverage of ~503–1003 with next-generation sequencing
platforms. These data will provide a rich resource for
further investigation of heteroplasmy. Regardless of the
strategy and average coverage obtained, our results indi-
cate that accurate calling of heteroplasmic positions
requires the analysis of control data and an appropriate
statistical model to generate appropriate criteria. With
such appropriate criteria for avoiding false positives due
to sequencing errors, high-throughput sequencing plat-
forms can provide a reliable genome-wide heteroplasmy
map, which can provide further insights into mtDNA-
related diseases and the evolution of mtDNA.The AmericSupplemental Data
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